Citigroup Maintains Buy on MyoKardia, Raises Price Target to $87

Citigroup maintains MyoKardia (NASDAQ:MYOK) with a Buy and raises the price target from $70 to $87.

Benzinga · 12/20/2019 13:30

Citigroup maintains MyoKardia (NASDAQ:MYOK) with a Buy and raises the price target from $70 to $87.